首页> 外文OA文献 >Combined immunization using DNA-Sm14 and DNA-Hsp65 increases CD8+ memory T cells, reduces chronic pathology and decreases egg viability during Schistosoma mansoni infection
【2h】

Combined immunization using DNA-Sm14 and DNA-Hsp65 increases CD8+ memory T cells, reduces chronic pathology and decreases egg viability during Schistosoma mansoni infection

机译:在曼氏血吸虫感染期间使用DNA-Sm14和DNA-Hsp65联合免疫可增加CD8 +记忆T细胞,减少慢性病理并降低卵生存力

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Abstract Background Schistosomiasis is one of the most important neglected diseases found in developing countries and affects 249 million people worldwide. The development of an efficient vaccination strategy is essential for the control of this disease. Previous work showed partial protection induced by DNA-Sm14 against Schistosoma mansoni infection, whereas DNA-Hsp65 showed immunostimulatory properties against infectious diseases, autoimmune diseases, cancer and antifibrotic properties in an egg-induced granuloma model. Methods C57BL/6 mice received 4 doses of DNA-Sm14 (100 μg/dose) and DNA-Hsp65 (100 μg/dose), simultaneously administrated, or DNA-Sm14 alone, once a week, during four weeks. Three groups were included: 1- Control (no immunization); 2- DNA-Sm14; 3- DNA-Sm14/DNA-Hsp65. Two weeks following last immunization, animals were challenged subcutaneously with 30 cercariae. Fifteen, 48 and 69 days after infection splenocytes were collected to evaluate the number of CD8+ memory T cells (CD44highCD62low) using flow cytometry. Forty-eight days after challenge adult worms were collected by portal veins perfusion and intestines were collected to analyze the intestinal egg viability. Histological, immunohistochemical and soluble quantification of collagen and α-SMA accumulation were performed on the liver. Results In the current work, we tested a new vaccination strategy using DNA-Sm14 with DNA-Hsp65 to potentiate the protection against schistosomiasis. Combined vaccination increased the number of CD8+ memory T cells and decreased egg viability on the intestinal wall of infected mice. In addition, simultaneous vaccination with DNA-Sm14/DNA-Hsp65 reduced collagen and α-SMA accumulation during the chronic phase of granuloma formation. Conclusion Simultaneous vaccination with DNA-Sm14/DNA-Hsp65 showed an immunostimulatory potential and antifibrotic property that is associated with the reduction of tissue damage on Schistosoma mansoni experimental infection.
机译:摘要背景血吸虫病是发展中国家发现的最重要的被忽视疾病之一,全世界有2.49亿人受到感染。开发有效的疫苗接种策略对于控制这种疾病至关重要。先前的工作显示了DNA-Sm14诱导的曼氏血吸虫感染的部分保护作用,而DNA-Hsp65在鸡蛋诱导的肉芽肿模型中表现出了针对感染性疾病,自身免疫性疾病,癌症和抗纤维化特性的免疫刺激特性。方法C57BL / 6小鼠在4周内每周一次接受4剂DNA-Sm14(100μg/剂量)和DNA-Hsp65(100μg/剂量),或每周一次单独给药。包括三组:1-对照(无免疫); 2-DNA-Sm14; 3-DNA-Sm14 / DNA-Hsp65。上次免疫后两周,用30只尾c皮下攻击动物。感染后第15、48和69天,使用流式细胞仪收集脾细胞以评估CD8 +记忆T细胞(CD44highCD62low)的数量。攻击后四十八天,通过门静脉灌注收集成虫,并收集肠以分析肠卵的存活力。在肝脏上进行胶原,α-SMA积累的组织学,免疫组化和可溶性定量分析。结果在当前工作中,我们测试了使用DNA-Sm14和DNA-Hsp65的新疫苗接种策略,以增强针对血吸虫病的保护作用。联合疫苗接种增加了CD8 +记忆T细胞的数量,并降低了感染小鼠肠壁上的卵生存力。此外,在肉芽肿形成的慢性期,同时接种DNA-Sm14 / DNA-Hsp65可以减少胶原蛋白和α-SMA的积累。结论同时接种DNA-Sm14 / DNA-Hsp65疫苗具有免疫刺激性和抗纤维化特性,与减少曼氏血吸虫实验性感染的组织损伤有关。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号